Literature DB >> 19888565

[Drug-induced osteopathies. Drugs, pathogenesis, forms, diagnosis, prevention and therapy].

R Bartl1, C Bartl, R Gradinger.   

Abstract

A number of drugs can have "side effects" on bone metabolism and formation, causing bone atrophy, impaired mineralisation, as well as osteonecrosis. In both clinical and general practitioner settings, these forms of bone damage have been hitherto considered as adverse drug side effects and have received insufficient attention; moreover, they have not been the subject of patient information. Preventive measures are not instigated prior to initiation of medication and even after onset of bone damage, therapeutic strategies are poorly implemented. Even fracture healing with its complex, staged course can be both positively and negatively influenced by a number of drugs and these effects require monitoring. Recommendations regarding practical screening and therapy of drug-induced osteopathies are presented.

Entities:  

Mesh:

Year:  2009        PMID: 19888565     DOI: 10.1007/s00132-009-1436-4

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  22 in total

1.  Osteopenia in HIV-infected patients: is it the disease or is it the treatment?

Authors:  H Knobel; A Guelar; G Vallecillo; X Nogués; A Díez
Journal:  AIDS       Date:  2001-04-13       Impact factor: 4.177

Review 2.  Drugs and fracture repair.

Authors:  Per Aspenberg
Journal:  Acta Orthop       Date:  2005-12       Impact factor: 3.717

Review 3.  Incidence and prevalence of medication-induced osteoporosis: evidence-based review.

Authors:  Juliette Allport
Journal:  Curr Opin Rheumatol       Date:  2008-07       Impact factor: 5.006

Review 4.  Anti-epileptic medication and bone health.

Authors:  S J Petty; T J O'Brien; J D Wark
Journal:  Osteoporos Int       Date:  2006-11-08       Impact factor: 4.507

Review 5.  Depression and osteoporosis: epidemiology and potential mediating pathways.

Authors:  B Mezuk; W W Eaton; S H Golden
Journal:  Osteoporos Int       Date:  2007-09-01       Impact factor: 4.507

6.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

Review 7.  Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review.

Authors:  Florent Richy; Jean Bousquet; George E Ehrlich; Pierre J Meunier; Elliot Israel; Hirotoshi Morii; Jean-Pierre Devogelaer; Nicola Peel; Muriel Haim; Olivier Bruyere; Jean-Yves Reginster
Journal:  Osteoporos Int       Date:  2003-04-23       Impact factor: 4.507

8.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

9.  Oral anticoagulants and the risk of osteoporotic fractures among elderly.

Authors:  Danielle Pilon; Anne-Marie Castilloux; Marc Dorais; Jacques LeLorier
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-05       Impact factor: 2.890

10.  Effects of propranolol on bone metabolism in the rat.

Authors:  B Minkowitz; A L Boskey; J M Lane; H S Pearlman; V J Vigorita
Journal:  J Orthop Res       Date:  1991-11       Impact factor: 3.494

View more
  2 in total

Review 1.  Osteoporosis and polypharmacy.

Authors:  M Gosch; M Jeske; C Kammerlander; T Roth
Journal:  Z Gerontol Geriatr       Date:  2012-08       Impact factor: 1.281

2.  [Osteomalacia and vitamin D deficiency].

Authors:  C P Rader; N Corsten; O Rolf
Journal:  Orthopade       Date:  2015-09       Impact factor: 1.087

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.